Durham, NORTH%20CAROLINA4 Active Studies

Ulcerative Colitis Clinical Trials in Durham, NORTH%20CAROLINA

Find 4 actively recruiting ulcerative colitis clinical trials in Durham, NORTH%20CAROLINA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
131
Enrolling

Recruiting Ulcerative Colitis Studies in Durham

RecruitingDurham, NORTH%20CAROLINANCT05785819

A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia

The purpose of this study is to evaluate the efficacy and safety of VLX-1005, a 12-lipoxygenase (12-LOX) enzyme inhibitor in treating heparin induced thrombocytopenia (HIT). Participants with suspecte...

60 participants
Veralox Therapeutics
View Study Details
RecruitingDurham, NORTH%20CAROLINANCT06315738

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis

The primary objective of this study is to determine the safety and tolerability of two dose levels (0.5 mL/kg and 1.0 mL/kg) of once daily (QD) via IV route of administration of ST266 in treating pati...

36 participants
Noveome Biotherapeutics, formerly Stemnion
View Study Details
RecruitingDurham, NORTH%20CAROLINANCT05642455

SPEARHEAD-3 Pediatric Study

This is a pediatric basket study to investigate the safety and efficacy of afamitresgene autoleucel in HLA-A\*02 eligible and MAGE-A4 positive subjects aged 2-17 years of age with advanced cancers....

20 participants
Adaptimmune
View Study Details
RecruitingDurham, NORTH%20CAROLINANCT05487599

A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)

Study J3Z-MC-OJAE is a Phase 1/2, multicenter, open-label, dose-finding study of LY3884961 evaluating the safety and tolerability in adults with peripheral manifestations of GD. Up to 3 dose levels o...

15 participants
Prevail Therapeutics
View Study Details

About Ulcerative Colitis Clinical Trials in Durham

Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the innermost lining of the colon and rectum. It typically presents with bloody diarrhea, abdominal pain, and urgency. Treatment includes aminosalicylates, corticosteroids, immunosuppressants, and biologics.

There are currently 4 ulcerative colitis clinical trials recruiting participants in Durham, NORTH%20CAROLINA. These studies are seeking a combined 131 participants. Research is being sponsored by Veralox Therapeutics, Noveome Biotherapeutics, formerly Stemnion, Adaptimmune and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ulcerative Colitis Clinical Trials in Durham — FAQ

Are there ulcerative colitis clinical trials in Durham?

Yes, there are 4 ulcerative colitis clinical trials currently recruiting in Durham, NORTH%20CAROLINA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Durham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Durham research site will contact you about next steps.

Are clinical trials in Durham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Durham studies also compensate for your time and travel.

What ulcerative colitis treatments are being tested?

The 4 active trials in Durham are testing new therapies including novel drugs, biologics, and treatment approaches for ulcerative colitis.

Data updated March 2, 2026 from ClinicalTrials.gov